226 related articles for article (PubMed ID: 24626198)
1. Activating FGFR3 mutations cause mild hyperplasia in human skin, but are insufficient to drive benign or malignant skin tumors.
Duperret EK; Oh SJ; McNeal A; Prouty SM; Ridky TW
Cell Cycle; 2014; 13(10):1551-9. PubMed ID: 24626198
[TBL] [Abstract][Full Text] [Related]
2. A positive FGFR3/FOXN1 feedback loop underlies benign skin keratosis versus squamous cell carcinoma formation in humans.
Mandinova A; Kolev V; Neel V; Hu B; Stonely W; Lieb J; Wu X; Colli C; Han R; Pazin MJ; Ostano P; Dummer R; Brissette JL; Dotto GP
J Clin Invest; 2009 Oct; 119(10):3127-37. PubMed ID: 19729838
[TBL] [Abstract][Full Text] [Related]
3. Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans.
Logié A; Dunois-Lardé C; Rosty C; Levrel O; Blanche M; Ribeiro A; Gasc JM; Jorcano J; Werner S; Sastre-Garau X; Thiery JP; Radvanyi F
Hum Mol Genet; 2005 May; 14(9):1153-60. PubMed ID: 15772091
[TBL] [Abstract][Full Text] [Related]
4. FGFR3 mutations in seborrheic keratoses are already present in flat lesions and associated with age and localization.
Hafner C; Hartmann A; van Oers JM; Stoehr R; Zwarthoff EC; Hofstaedter F; Landthaler M; Vogt T
Mod Pathol; 2007 Aug; 20(8):895-903. PubMed ID: 17585316
[TBL] [Abstract][Full Text] [Related]
5. High frequency of FGFR3 mutations in adenoid seborrheic keratoses.
Hafner C; van Oers JM; Hartmann A; Landthaler M; Stoehr R; Blaszyk H; Hofstaedter F; Zwarthoff EC; Vogt T
J Invest Dermatol; 2006 Nov; 126(11):2404-7. PubMed ID: 16778799
[TBL] [Abstract][Full Text] [Related]
6. Activation of fibroblast growth factor receptor 3 and oncogene-induced senescence in skin tumours.
Hida Y; Kubo Y; Arase S
Br J Dermatol; 2009 Jun; 160(6):1258-63. PubMed ID: 19298285
[TBL] [Abstract][Full Text] [Related]
7. FGFR3 mutations in epidermal nevi and seborrheic keratoses: lessons from urothelium and skin.
Hafner C; Hartmann A; Vogt T
J Invest Dermatol; 2007 Jul; 127(7):1572-3. PubMed ID: 17568799
[TBL] [Abstract][Full Text] [Related]
8. FGFR3 mutations in benign skin tumors.
Hafner C; Vogt T; Hartmann A
Cell Cycle; 2006 Dec; 5(23):2723-8. PubMed ID: 17172848
[TBL] [Abstract][Full Text] [Related]
9. Somatic FGFR3 and PIK3CA mutations are present in familial seborrhoeic keratoses.
Hafner C; Vogt T; Landthaler M; Müsebeck J
Br J Dermatol; 2008 Jul; 159(1):214-7. PubMed ID: 18503601
[TBL] [Abstract][Full Text] [Related]
10. Sustained Akt Activity Is Required to Maintain Cell Viability in Seborrheic Keratosis, a Benign Epithelial Tumor.
Neel VA; Todorova K; Wang J; Kwon E; Kang M; Liu Q; Gray N; Lee SW; Mandinova A
J Invest Dermatol; 2016 Mar; 136(3):696-705. PubMed ID: 26739095
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor receptor 3 mutations in epidermal nevi and associated low grade bladder tumors.
Hernández S; Toll A; Baselga E; Ribé A; Azua-Romeo J; Pujol RM; Real FX
J Invest Dermatol; 2007 Jul; 127(7):1664-6. PubMed ID: 17255960
[TBL] [Abstract][Full Text] [Related]
12. Multiple oncogenic mutations and clonal relationship in spatially distinct benign human epidermal tumors.
Hafner C; Toll A; Fernández-Casado A; Earl J; Marqués M; Acquadro F; Méndez-Pertuz M; Urioste M; Malats N; Burns JE; Knowles MA; Cigudosa JC; Hartmann A; Vogt T; Landthaler M; Pujol RM; Real FX
Proc Natl Acad Sci U S A; 2010 Nov; 107(48):20780-5. PubMed ID: 21078999
[TBL] [Abstract][Full Text] [Related]
13. [R248C FGFR3 mutation. Effect on cell growth, apoptosis and attachment in HaCaT keratinocytes].
Hafner C; Hartmann A
Pathologe; 2010 Oct; 31 Suppl 2():221-4. PubMed ID: 20711586
[TBL] [Abstract][Full Text] [Related]
14. Alterations in epidermal biochemistry as a consequence of stage-specific genetic changes in skin carcinogenesis.
Yuspa SH; Kilkenny A; Cheng C; Roop D; Hennings H; Kruszewski F; Lee E; Strickland J; Greenhalgh DA
Environ Health Perspect; 1991 Jun; 93():3-10. PubMed ID: 1773799
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern.
Hafner C; López-Knowles E; Luis NM; Toll A; Baselga E; Fernández-Casado A; Hernández S; Ribé A; Mentzel T; Stoehr R; Hofstaedter F; Landthaler M; Vogt T; Pujol RM; Hartmann A; Real FX
Proc Natl Acad Sci U S A; 2007 Aug; 104(33):13450-4. PubMed ID: 17673550
[TBL] [Abstract][Full Text] [Related]
16. K-Ras and β-catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder.
Ahmad I; Singh LB; Foth M; Morris CA; Taketo MM; Wu XR; Leung HY; Sansom OJ; Iwata T
Dis Model Mech; 2011 Jul; 4(4):548-55. PubMed ID: 21504907
[TBL] [Abstract][Full Text] [Related]
17. Segmentally arranged seborrhoeic keratoses with impending atypia and squamous cell carcinoma in an elderly woman.
Livingstone E; Hillen U; Hafner C; Piel S; Groesser L; Schadendorf D; Happle R
Br J Dermatol; 2015 Jun; 172(6):1642-1645. PubMed ID: 25420590
[TBL] [Abstract][Full Text] [Related]
18. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
[TBL] [Abstract][Full Text] [Related]
19. FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR.
Li L; Zhang S; Li H; Chou H
BMC Cancer; 2019 Oct; 19(1):963. PubMed ID: 31619201
[TBL] [Abstract][Full Text] [Related]
20. [Genetic basis of seborrheic keratosis and epidermal nevi].
Hafner C; Hafner H; Groesser L
Pathologe; 2014 Sep; 35(5):413-23. PubMed ID: 25187080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
